www.ema.europa.eu Eight new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended eight medicines for approval at its November 2023 meeting.The CHMP adopted a positive opinion for Omjjara* (momelotinib), for the treatment of myelofibrosis, a rare blood cancer...

www.ema.europa.eu The European Medicines Agency (EMA) is relaunching its corporate website on Tuesday 5 December.  From day one, EMA is giving its website a fresh look and feel. The website will also feature a new, simple medicines search, clearer navigation and a revamped What’s new...

www.ema.europa.eu This year marks the 10th anniversary of the International Coalition of Medicines Regulatory Authorities (ICMRA). ICMRA was established in December 2013 by eight regulators to address a need for a global governance mechanism and stronger cooperation. Today, ICMRA consists...

www.ema.europa.eu The anniversary will be celebrated during ICMRA's annual summit and Plenary in Melbourne on 13-16 November, hosted by the Therapeutic Goods Administration (TGA) of Australia. ICMRA members will exchange views and discuss topics such as the use of artificial intelligence...

www.ema.europa.eu The Heads of Medicines Agencies (HMA), the European Commission (EC) and EMA have published for the first time electronic product information (ePI) for selected human medicines harmonised across the European Union (EU). The product information of a medicine includes its...

www.ema.europa.eu The Heads of Medicines Agencies (HMA), the European Commission (EC) and EMA have published for the first time electronic product information (ePI) for selected human medicines harmonised across the European Union (EU). The product information of a medicine includes its...